Just weeks from the deadline for reporting serious adverse events (SAEs) under the Modernization of Cosmetics Regulation Act, the US Food and Drug Administration has updated instructions for filing reports to make the process easier, while promoting a soon-to-launch electronic submission platform.
FDA Updates Instructions For Reporting Serious Adverse Events Under MoCRA
The US Food and Drug Administration simplifies instructions for filing reports on serious adverse events under the Modernization of Cosmetics Regulation Act; promotes soon-to-launch electronic-reporting platform.
